Very late heart transplant rejection is associated with microvascular injury, complement deposition and progression to cardiac allograft vasculopathy

American Journal of Transplantation

Volumn 11, Issue 7, 2011, Pages 1478-1487

  Loupy, A ^a,b,c   Cazes, A ^b,d   Guillemain, R ^d   Amrein, C ^d   Hedjoudje, A ^d   Tible, M ^d   Pezzella, V ^d   Fabiani, J N ^d   Suberbielle, C ^e   Nochy, D ^d   Hill, G S ^d   Empana, J P ^b,c   Jouven, X ^b,c   Bruneval, P ^b,c,d   Van Huyen, J P Duong ^b,c,d  

^a HÔPITAL NECKER ENFANTS MALADES   (France)

^b UNIVERSITÉ PARIS DESCARTES   (France)

^c PARIS CARDIOVASCULAR RESEARCH CENTER   (France)

^d HÔPITAL EUROPÉEN GEORGES POMPIDOU   (France)

^e SAINT LOUIS HOSPITAL   (France)

Author keywords

Antibodies; heart transplantation; rejection; vasculopathy

Indexed keywords

ANTIBODY; CD68 ANTIGEN; COMPLEMENT COMPONENT C3D; COMPLEMENT COMPONENT C4D;

ADULT; ARTICLE; BLOOD VESSEL INJURY; CARDIAC ALLOGRAFT VASCULOPATHY; CARDIAC GRAFT REJECTION; CELL DAMAGE; CELL INFILTRATION; COMPLEMENT ACTIVATION; COMPLEMENT DEPOSITION; CONTROLLED STUDY; DISEASE COURSE; DISEASE SEVERITY; FEMALE; FOLLOW UP; GRAFT RECIPIENT; HEART MUSCLE BIOPSY; HEART MUSCLE CELL; HISTOPATHOLOGY; HUMAN; IMMUNOPHENOTYPING; MACROPHAGE; MAJOR CLINICAL STUDY; MALE; MICROCIRCULATION; PREVALENCE; PRIORITY JOURNAL; SURVIVAL;

ADULT; ANTIBODIES; COMPLEMENT ACTIVATION; FEMALE; FOLLOW-UP STUDIES; GRAFT REJECTION; HEART TRANSPLANTATION; HUMANS; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; TISSUE DONORS;

EID: 79959845160     PISSN: 16006135     EISSN: 16006143     Source Type: Journal    
DOI: 10.1111/j.1600-6143.2011.03563.x     Document Type: Article

References (37)

1. Taylor DO, Edwards LB, Boucek MM, et al,. Registry of the International Society for Heart and Lung Transplantation: Twenty-third official adult heart transplantation report-2006. J Heart Lung Transplant 2006; 25: 869-879. (Pubitemid 44143013)
2. Nwakanma LU, Williams JA, Weiss ES, et al,. Influence of pretransplant panel-reactive antibody on outcomes in 8,160 heart transplant recipients in recent era. Ann Thorac Surg 2007; 84: 1556-1562. Discussion 1562-1553.
3. Reed EF, Demetris AJ, Hammond E, et al., Acute antibody-mediated rejection of cardiac transplants. J Heart Lung Transplant 2006; 25: 153-159. (Pubitemid 43156365)
4. Murata K, Baldwin WM, 3rd,. Mechanisms of complement activation, C4d deposition, and their contribution to the pathogenesis of antibody-mediated rejection. Transplant Rev (Orlando) 2009; 23: 139-150.
5. Tan CD, Sokos GG, Pidwell DJ, et al,. Correlation of donor-specific antibodies, complement and its regulators with graft dysfunction in cardiac antibody-mediated rejection. Am J Transplant 2009; 9: 2075-2084.
6. Stewart S, Winters GL, Fishbein MC, et al,. Revision of the 1990 working formulation for the standardization of nomenclature in the diagnosis of heart rejection. J Heart Lung Transplant 2005; 24: 1710-1720. (Pubitemid 41641841)
7. Kfoury AG, Hammond ME,. Controversies in defining cardiac antibody-mediated rejection: Need for updated criteria. J Heart Lung Transplant 2010; 29: 389-394.
8. Michaels PJ, Espejo ML, Kobashigawa J, et al,. Humoral rejection in cardiac transplantation: Risk factors, hemodynamic consequences and relationship to transplant coronary artery disease. J Heart Lung Transplant 2003; 22: 58-69. (Pubitemid 36071418)
9. Tan CD, Baldwin WM, 3rd, Rodriguez ER,. Update on cardiac transplantation pathology. Arch Pathol Lab Med 2007; 131: 1169-1191. (Pubitemid 47260523)
10. Wehner J, Morrell CN, Reynolds T, Rodriguez ER, Baldwin WM, 3rd,. Antibody and complement in transplant vasculopathy. Circ Res 2007; 100: 191-203. (Pubitemid 46208719)
11. Kobashigawa J, Mehra M, West L, et al,. Report from a consensus conference on the sensitized patient awaiting heart transplantation. J Heart Lung Transplant 2009; 28: 213-225.
12. Sis B, Mengel M, Haas M, et al,. Banff '09 Meeting report: Antibody mediated graft deterioration and implementation of Banff working groups. Am J Transplant 2010; 10: 464-71
13. Colvin RB,. Antibody-mediated renal allograft rejection: Diagnosis and pathogenesis. J Am Soc Nephrol 2007; 18: 1046-1056. (Pubitemid 46536891)
14. Almuti K, Haythe J, Dwyer E, et al,. The changing pattern of humoral rejection in cardiac transplant recipients. Transplantation 2007; 84: 498-503. (Pubitemid 47312161)
15. Wu GW, Kobashigawa JA, Fishbein MC, et al,. Asymptomatic antibody-mediated rejection after heart transplantation predicts poor outcomes. J Heart Lung Transplant 2009; 28: 417-422.
16. Colvin RB,. Pathology of chronic humoral rejection. Contrib Nephrol 2009; 162: 75-86.
17. Sis B, Halloran PF,. Endothelial transcripts uncover a previously unknown phenotype: C4d-negative antibody-mediated rejection. Curr Opin Organ Transplant; 15: 42-48.
18. Haas M, Montgomery RA, Segev DL, et al,. Subclinical acute antibody-mediated rejection in positive crossmatch renal allografts. Am J Transplant 2007; 7: 576-585. (Pubitemid 46376440)
19. Loupy A, Suberbielle-Boissel C, Hill GS, et al,. Outcome of subclinical antibody-mediated rejection in kidney transplant recipients with preformed donor-specific antibodies. Am J Transplant 2009; 9: 2561-2570.
20. Gloor JM, Cosio FG, Rea DJ, et al,. Histologic findings one year after positive crossmatch or ABO blood group incompatible living donor kidney transplantation. Am J Transplant 2006; 6: 1841-1847. (Pubitemid 44024955)
21. Lerut E, Naesens M, Kuypers DR, Vanrenterghem Y, Van Damme B,. Subclinical peritubular capillaritis at 3 months is associated with chronic rejection at 1 year. Transplantation 2007; 83: 1416-1422. (Pubitemid 46934063)
22. Rodriguez ER, Skojec DV, Tan CD, et al,. Antibody-mediated rejection in human cardiac allografts: Evaluation of immunoglobulins and complement activation products C4d and C3d as markers. Am J Transplant 2005; 5: 2778-2785.
23. Klingenberg R, Koch A, Schnabel PA, et al,. Allograft rejection of ISHLT grade >/= 3A occurring late after heart transplantation-a distinct entity? J Heart Lung Transplant 2003; 22: 1005-1013. (Pubitemid 37075939)
24. Mulla NF, Johnston JK, Vander Dussen L, et al,. Late rejection is a predictor of transplant coronary artery disease in children. J Am Coll Cardiol 2001; 37: 243-250. (Pubitemid 32051746)
25. Loupy A, Suberbielle-Boissel C, Zuber J, et al,. Combined posttransplant prophylactic IVIg/anti-CD 20/plasmapheresis in kidney recipients with preformed donor-specific antibodies: A pilot study. Transplantation 2010; 89: 1403-1410.
26. Mehra MR, Crespo-Leiro MG, Dipchand A, et al,. International Society for Heart and Lung Transplantation working formulation of a standardized nomenclature for cardiac allograft vasculopathy-2010. J Heart Lung Transplant 2010; 29: 717-727.
27. Einecke G, Sis B, Reeve J, et al,. Antibody-mediated microcirculation injury is the major cause of late kidney transplant failure. Am J Transplant 2009; 9: 2520-2531.
28. Kfoury AG, Hammond ME, Snow GL, et al,. Cardiovascular mortality among heart transplant recipients with asymptomatic antibody-mediated or stable mixed cellular and antibody-mediated rejection. J Heart Lung Transplant 2009; 28: 781-784.
29. Fedson SE, Daniel SS, Husain AN,. Immunohistochemistry staining of C4d to diagnose antibody-mediated rejection in cardiac transplantation. J Heart Lung Transplant 2008; 27: 372-379. (Pubitemid 351418240)
30. Holt DB, Liapis H, Mohanakumar T, et al,. Complement fragment C4d and C3d deposition in pediatric heart recipients with a positive crossmatch. J Heart Lung Transplant 2008; 27: 1073-1078.
31. Keslar K, Rodriguez ER, Tan CD, Starling RC, Heeger PS,. Complement gene expression in human cardiac allograft biopsies as a correlate of histologic grade of injury. Transplantation 2008; 86: 1319-1321.
32. Moseley EL, Atkinson C, Sharples LD, Wallwork J, Goddard MJ,. Deposition of C4d and C3d in cardiac transplants: A factor in the development of coronary artery vasculopathy. J Heart Lung Transplant 2010; 29: 417-423.
33. Reeve J, Einecke G, Mengel M, et al,. Diagnosing rejection in renal transplants: A comparison of molecular- and histopathology-based approaches. Am J Transplant 2009; 9: 1802-1810.
34. Hirohashi T, Uehara S, Chase CM, et al,. Complement independent antibody-mediated endarteritis and transplant arteriopathy in mice. Am J Transplant 2010; 10: 510-517.
35. Loupy A, Hill GS, Suberbielle C, et al,. Significance of C4d Banff scores in early protocol biopsies of kidney transplant recipients with preformed donor-specific antibodies (DSA). Am J Transplant 2011; 11: 56-65.
36. Mengel M, Sis B, Kim D, et al,. The molecular phenotype of heart transplant biopsies: Relationship to histopathological and clinical variables. Am J Transplant 2010; 10: 2105-2115.
37. Smith JD, Banner NR, Hamour IM, et al,. De novo donor HLA-specific antibodies after heart transplantation are an independent predictor of poor patient survival. Am J Transplant 2011; 11: 312-319.